🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great piece of work from the Green lab. The Smyd3 - map3k2 signaling at play in prostate cancer too! Really happy we were able to help, and it was a fantastic experience to host Sabeen for few months (and some extra, for once a positive outcome of covid!)

Great piece of work from the Green lab. The Smyd3 - map3k2 signaling at play in prostate cancer too! Really happy we were able to help, and it was a fantastic experience to host Sabeen for few months (and some extra, for once a positive outcome of covid!)

#Communiqué 🗞️ Une protéine particulièrement abondante dans les cancers du sein réfractaires aux traitements conventionnels s’avèrerait responsable du développement de métastases. La cibler permettrait d'augmenter l’espérance de survie des malades. 👉 cnrs.fr/fr/presse/trai…

#Découverte // Traitement du cancer du sein agressif : cibler une nouvelle protéine responsable du développement de métastases pour augmenter l’espérance de survie des malades ! Une étude franco-américaine menée IAB parue dans Cell Discovery 🔗bit.ly/3HDbDID

Complete study in open access Cell Discovery : rdcu.be/dxnRW A massive work from A. Casanova in the KmeDynamics_Reynoirdlab at IAB Université Grenoble Alpes and with a fantastic collaboration with Pawel K. Mazur from MD Anderson Cancer Center

The KmeDynamics_Reynoirdlab is proud to be supported once again by the Gefluc Grenoble in 2024. Last time it happened, the association was the first to fund our project on SMYD2 and breast cancer metastasis, recently accepted Cell Discovery > rdcu.be/dxnRW.

À Université Grenoble Alpes, un laboratoire de recherches @IAB_Officie vient de faire une découverte importante dans la prise en charge des cancers du sein agressifs. Explications avec Nicolas Reynoird, chercheur au CNRS. france3-regions.francetvinfo.fr/auvergne-rhone…

Congratulations to KmeDynamics_Reynoirdlab and Pawel K. Mazur for the identification of a protein responsible for the development of #metastases in #breastcancer. This discovery could increase patients’ survival expectancy, by targeting this protein.

📢 | The IAB is inviting for declarations of interest for the position of #Director of the Institute for its next quinquennial program. 🗓️ Deadline for inquiries: May 31st 2024 More information on our website: iab-grenoble.fr/fr/actualites/…

Les recherches du Dr KmeDynamics_Reynoirdlab et son équipe, (Cell Discovery) montrent que bloquer la protéine SMYD2 peut prévenir les métastases, principale cause de mortalité dans le cancer du sein agressif. lire + : rdcu.be/dxnRW IAB Pawel K. Mazur Université Grenoble Alpes

À big congrats once more to Alexandre Casanova and the rest of the KmeDynamics_Reynoirdlab, together with all our great collaborators (Pawel K. Mazur, NovelTargetsLab_Palencia_Inserm, LeRomancer&Trédan Lab and others without an X account...) for this piece of work. Kudos all on to the next adventure together!

Congrats for all the work leading to this beautiful story!

📣The Levy lab at BGU is hiring. We are looking for new team members (MSc, PhD students and post-docs) excited about chromatin biology, epigenetics and lysine methylation signaling in health and disease. Visit our lab website for more info: lifewp.bgu.ac.il/wp/ledan Please RT📣.

🚨We are delighted to announce that Julio Liu (Niels Mailand group - Niels Mailand Lab), will be presenting his research at our next session, which will bring together Anna Campalans Anna Campalans and Tanveer Ahmad KmeDynamics_Reynoirdlab. Join us for what promises to be an exciting session🤩

Cc Gustave Roussy Institut national du cancer Institut Curie Inserm CNRS 🌍 Ministère de la Santé et de l'Accès aux soins Gouvernement IAB Barbara Pistilli Elie Rassy Nicolas Scotté

Un important rappel de l'importance dans la lutte contre le cancer du sein et des avancées de la recherche, incluant notamment les travaux et une interview de KmeDynamics_Reynoirdlab